The Bioseal Vascular Study

Inclusion criteria

• Subjects between 18 and 75 years of age;
• Undergoing elective vascular surgical procedures and with the presence of an appropriate Target Bleeding Site (TBS) requiring an adjunct to achieve hemostasis as identified intra-operatively by the surgeon ;
• Able and willing to comply with procedures required by protocol;
• Signed and dated written informed consent prior to any study related procedures.

Exclusion criteria

• Subjects with any intra-operative findings that may preclude conducting of the study procedures;
• Intended use of Fibrin Sealants (including autologous Fibrin Sealants) other than Bioseal on the TBS;
• Subjects with known intolerance to blood products or to one of the components of the study product or unwilling to receive blood products;
• Subjects with known allergies to or previously used porcine derived products;
• Female subjects who are known breastfeeding or pregnant or intend to become pregnant during the clinical study period.
• The subject, in the opinion of the investigator, would not be suitable for participation in the study.
• Subjects who participated in another trial within 30 days prior to the planned start of treatment.